Borderline Personality Disorder Clinical Trial
Official title:
Training of Neural Responding With fMRI Neurofeedback in Borderline Personality Disorder
Emotion-related brain activation is made visible for patients via neurofeedback with the aim to improve discriminability of emotional arousal and emotion regulation. With functional magnetic resonance imaging (fMRI), information of current brain activation is imaged and fed back to the patient via a visual display. Patients with borderline personality disorder (BPD) usually hyper-activate brain regions associated with emotion. In this study, BPD patients will be provided with neurofeedback from the amygdala, which is crucial for the processing of emotions. The aim of the study is to observe, whether amygdala-neurofeedback would help BPD patients to improve emotion regulation. Compared to a control condition, improved brain self-regulation and emotion regulation is expected with three neurofeedback training sessions.
Patients with BPD show increased emotional reactivity, slow return to baseline, and severe
emotion dysregulation symptoms. On the neural level, BPD patients hyper-activate the amygdala
and hypo-activate the prefrontal cortex in response to emotional stimuli. The prefrontal
cortex and the amygdala are crucial nodes of the brain's emotion regulation network and thus
it is assumed, that dysregulation within this network is key to BPD symptoms. Psychotherapy
treatments specialized for BPD teach patients to monitor emotional arousal and to develop
emotion regulation skills. However in the long run and despite of important therapeutic
advances, the majority of BPD patients keep reporting significant impairments in functioning
after psychotherapy.
To explore new types of therapy in BPD, the investigators have applied real-time fMRI
neurofeedback, where patients are provided with their brain activation via a visual display.
In previous work they found that BPD patients and healthy participants can down-regulate
amygdala activation with real-time fMRI neurofeedback, and increase connectivity between the
amygdala and the prefrontal cortex. Yet, we do not yet fully understand the potential effects
of amygdala neurofeedback on emotion.
BPD patients (n=25) participate in a three-session fMRI neurofeedback training with 2-7 days
between sessions (within 2 weeks). The effect of the training will be measured before and
after training. Primarily, the investigators expect an improvement in emotion regulation,
secondarily, reductions in BPD symptoms are expected.
Hypotheses:
With fMRI neurofeedback, BPD patients improve significantly in self-report and
psychophysiological measures of emotion regulation with fMRI neurofeedback training. BPD
patients show significantly reduced symptom severity in self-report measures with
neurofeedback training.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04856449 -
DBT Skills Plus EMDR for BPD and Trauma
|
N/A | |
Active, not recruiting |
NCT04587518 -
Five Factor Model Treatment for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT05651295 -
A Precision Medicine Approach to Target Engagement for Emotion Regulation
|
N/A | |
Completed |
NCT03677037 -
The Short-Term MBT Project
|
Phase 3 | |
Not yet recruiting |
NCT05989529 -
Delving Into Borderline Personality Disorder Clinical Trial Experiences
|
||
Completed |
NCT02518906 -
Evaluation of AIT Study
|
N/A | |
Completed |
NCT02068326 -
MBT in Groups for Adolescents With BPD or Subthreshold BPD Versus TAU - the M-GAB Randomized Controlled Trial
|
N/A | |
Recruiting |
NCT04296604 -
Transcranial Direct Current Stimulation (tDCS) Neuromodulation of Executive Function Across Neuropsychiatric Populations
|
N/A | |
Terminated |
NCT02149823 -
Examining Dose-Related Effects of Oxytocin on Social Cognition Across Populations
|
Phase 1 | |
Completed |
NCT02108990 -
Acetaminophen and Social Processes
|
Phase 2 | |
Not yet recruiting |
NCT01683136 -
Evaluation of the HBDL Coil Transcranial Magnetic Stimulation (TMS) Device - Feasibility Study for the Treatment of Borderline Personality Disorder
|
N/A | |
Completed |
NCT01635556 -
Evaluation of a Modified Dialectical Behavior Therapy Program
|
N/A | |
Completed |
NCT02988037 -
Adapted Dialectical Behaviour Therapy for Adolescents With Deliberate Self-Harm: A Pre-post Observational Study
|
N/A | |
Completed |
NCT02397031 -
Mindfulness and Interpersonal Effectiveness Skills in Borderline Personality Disorder
|
N/A | |
Terminated |
NCT01212588 -
Preliminary Trial of the Effect of Glucocorticoid Receptor Antagonist on Borderline Personality Disorder (BPD)
|
Phase 2 | |
Terminated |
NCT01103180 -
Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
|
Phase 2 | |
Terminated |
NCT00539188 -
N-Acetylcysteine in Adjunct to DBT for the Treatment of Self-Injurious Behavior in BPD
|
Phase 2 | |
Recruiting |
NCT05398627 -
Neurofeedback for Borderline Personality Disorder
|
N/A | |
Recruiting |
NCT03994510 -
SHame prOpensity in bOrderline Personality Disorder
|
N/A | |
Recruiting |
NCT06005129 -
Personality Change Study for Borderline Personality Disorder
|
N/A |